Sign Up to like & get
recommendations!
1
Published in 2022 at "Cell reports"
DOI: 10.1016/j.celrep.2022.110602
Abstract: Up to 15% of human cancers maintain their telomeres through a telomerase-independent mechanism, termed "alternative lengthening of telomeres" (ALT) that relies on homologous recombination between telomeric sequences. Emerging evidence suggests that the recombinogenic nature of…
read more here.
Keywords:
alt;
cancer cells;
alt cancer;
integrity alt ... See more keywords